Invention Grant
- Patent Title: Combinations of LSD1 inhibitors for the treatment of hematological malignancies
-
Application No.: US16084683Application Date: 2017-03-13
-
Publication No.: US11013698B2Publication Date: 2021-05-25
- Inventor: Filippo Ciceri , Serena Lunardi , Tamara Maes , Cristina Mascaro Crusat , Inigo Tirapu Fernandez De La Cuesta
- Applicant: Oryzon Genomics S.A.
- Applicant Address: ES Madrid
- Assignee: Oryzon Genomics S.A.
- Current Assignee: Oryzon Genomics S.A.
- Current Assignee Address: ES Madrid
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Priority: EP16382117 20160315
- International Application: PCT/EP2017/055763 WO 20170313
- International Announcement: WO2017/157813 WO 20170921
- Main IPC: A61K31/05
- IPC: A61K31/05 ; A61K31/12 ; A61P35/02 ; A61K31/135 ; A61K31/17 ; A61K31/203 ; A61K31/282 ; A61K31/015 ; A61K31/337 ; A61K31/4045 ; A61K31/4745 ; A61K31/475 ; A61K31/519 ; A61K31/555 ; A61K31/704 ; A61K31/7068 ; A61K31/19 ; A61P35/00 ; A61K31/496 ; A61K33/36 ; A61K31/64
Abstract:
The instant invention relates to combinations of the compound of formula (I) or pharmaceutically acceptable salts thereof with other active pharmaceutical ingredients pharmaceutical compositions comprising them, and their use as medicaments, particularly for the treatment of hematological malignancies.
Public/Granted literature
- US20190083417A1 COMBINATIONS OF LSD1 INHIBITORS FOR THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES Public/Granted day:2019-03-21
Information query
